EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis

Yuichiro Tsunemi iD, Wataru Naka iD

The Journal of Dermatology · 2025-01 · 52 (1) · 79-86

DOI: 10.1111/1346-8138.17455 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift The Journal of Dermatology, online erschienen am 10.09.2024. Verfasst von Yuichiro Tsunemi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Saitama Medical University Hospital, Saitama, Japan. Hauptthemen laut MEDLINE: Antifungal Agents, Tinea Pedis, Triazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Sato Pharmaceutical Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the clinical efficacy of short‐term, oral fosravuconazole (F‐RVCZ) therapy for tinea pedis, commonly known as athlete's foot. F‐RVCZ (equivalent to 100 mg ravuconazole) was administered orally once daily for 1 week for interdigital and vesicular tinea pedis and for 4 weeks for hyperkeratotic tinea pedis. Efficacy was evaluated based on mycological efficacy and clinical symptoms at Weeks 1, 4, and 8 for interdigital and vesicular tinea pedis and at Weeks 4, 8, and 12 for hyperkeratotic tinea pedis. Efficacy was confirmed at the end of treatment. Therapeutic efficacy increased over time from the end of treatment for both types of tinea pedis. All adverse drug reactions (ADRs) were within expectations and there were no cases of discontinuation due to ADRs or serious ADRs. Short‐term oral F‐RVCZ therapy is expected to be as effective or more effective than terbinafine and itraconazole, which have already been approved in Japan and may be a useful option for the treatment of tinea pedis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsTinea PedisTriazolesAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralDrug Administration ScheduleThiazolesTreatment Outcome

Stichwörter der Autor:innen

fosravuconazolehyperkeratoticoral antifungalshort‐term administrationtinea pedis

Substanzen

Antifungal AgentsER 30346ThiazolesTriazoles

Autor:innen und Institutionen

  • Department of Dermatology, Saitama Medical University Hospital, Saitama, Japan.
  • Naka Dermatology Clinic, Saitama, Japan.

ORCID-Profile: Yuichiro Tsunemi, Wataru Naka

Förderung

  • Sato Pharmaceutical Co., Ltd.

Zitieren

APA

Tsunemi, Y., & Naka, W. (2025). Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis. The Journal of Dermatology, 52(1), 79-86. https://doi.org/10.1111/1346-8138.17455

Vancouver

Tsunemi Y, Naka W. Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis. The Journal of Dermatology. 2025;52(1):79-86. doi:10.1111/1346-8138.17455

BibTeX
@article{Tsunemi2025,
  author = {Tsunemi, Yuichiro and Naka, Wataru},
  title = {Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis},
  journal = {The Journal of Dermatology},
  year = {2025},
  volume = {52},
  number = {1},
  pages = {79--86},
  doi = {10.1111/1346-8138.17455}
}
Kostenlos starten →